Atralin (tretinoin) gel, 0.05%

DRUG2 trials

Sponsors

Coria Laboratories, Ltd.

Conditions

Healthy

Phase 1

Clinical Evaluation of the Photoallergy Potential of Atralin Gel

CompletedNCT00603772

Coria Laboratories, Ltd.Healthy

Start: 2008-01-31End: 2008-03-31Target: 40Updated: 2008-05-06

Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

CompletedNCT00604032

Coria Laboratories, Ltd.Healthy

Start: 2008-01-31End: 2008-02-29Updated: 2008-03-28